<code id='CDC5D6A567'></code><style id='CDC5D6A567'></style>
    • <acronym id='CDC5D6A567'></acronym>
      <center id='CDC5D6A567'><center id='CDC5D6A567'><tfoot id='CDC5D6A567'></tfoot></center><abbr id='CDC5D6A567'><dir id='CDC5D6A567'><tfoot id='CDC5D6A567'></tfoot><noframes id='CDC5D6A567'>

    • <optgroup id='CDC5D6A567'><strike id='CDC5D6A567'><sup id='CDC5D6A567'></sup></strike><code id='CDC5D6A567'></code></optgroup>
        1. <b id='CDC5D6A567'><label id='CDC5D6A567'><select id='CDC5D6A567'><dt id='CDC5D6A567'><span id='CDC5D6A567'></span></dt></select></label></b><u id='CDC5D6A567'></u>
          <i id='CDC5D6A567'><strike id='CDC5D6A567'><tt id='CDC5D6A567'><pre id='CDC5D6A567'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:6
          Portrait of Suhas Gondi. -- health coverage from STAT
          Suhas Gondi of Brigham and Women's Hospital has researched and written about hospital boards increasingly being made up of private equity executives and others from outside medicine. Jonathan Wiggs/Globe Staff

          Discontent among Mass General Brigham doctors had been at a slow burn for years. But when an unexpected announcement from the chief executive titled “A message about our future” popped into inboxes one morning last month, that frustration seemed to fully ignite.

          Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

          advertisement

          But after years of feeling shut out of decisions amid grinding work schedules, many doctors worried the changes would lead to layoffs, demotions, and an even greater loss of autonomy. During an online ‘‘town hall’’ on April 4, they inundated leaders with skeptical questions. One physician asked how executives planned to build trust with faculty when so many felt “unheard, devalued, disempowered, and unseen.”

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          DeSantis says Trump could've 'come out more forcefully' during Jan. 6
          DeSantis says Trump could've 'come out more forcefully' during Jan. 6

          2:27FloridaGov.RonDeSantisrollsouthismilitarypolicyproposalduringaneventforhis2024presidentialcampai

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          BridgeBio heart drug succeeds in pivotal study

          AdobeAdrugdevelopedbythebiotechfirmBridgeBiototreatanincreasinglycommonheartconditionsucceededinitsm